Potassium Phosphate, Dibasic

CHEMBL1200459 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
174.2 g/mol
LogP
Phase
4

Potassium phosphate dibasic is an inorganic phosphate salt that serves as a source of potassium and phosphate ions for electrolyte replacement in patients with hypokalemia and hypophosphatemia. It is used in intravenous and oral formulations for phosphate and potassium supplementation in clinical settings.

Molecular Weight

174.1760 g/mol

TPSA

83.40 Ų

Mechanism of Action

Provides essential ions for maintaining fluid balance, nerve conduction, muscle contraction, and acid-base homeostasis. Supplementation corrects electrolyte imbalances.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanism

Provides essential ions for maintaining fluid balance, nerve conduction, muscle contraction, and acid-base homeostasis. Supplementation corrects electrolyte imbalances.

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=P([O-])([O-])O.[K+].[K+]

InChI

InChI=1S/2K.H3O4P/c;;1-5(2,3)4/h;;(H3,1,2,3,4)/q2*+1;/p-2

Molecular Formula

HK2O4P

HBD / HBA

1 / 4

Rotatable Bonds

0

Heavy Atoms

7

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

Potassium phosphate dibasic is an inorganic phosphate salt that serves as a source of potassium and phosphate ions for electrolyte replacement in patients with hypokalemia and hypophosphatemia. It is used in intravenous and oral formulations for phosphate and potassium supplementation in clinical settings.

Provides essential ions for maintaining fluid balance, nerve conduction, muscle contraction, and acid-base homeostasis. Supplementation corrects electrolyte imbalances.

Yes, Potassium Phosphate, Dibasic is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200459. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 24450. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.